Amicus appoints Bradley Campbell CBO
This article was originally published in Scrip
Amicus Therapeutics, a developer of therapies for rare and orphan diseases, has promoted Bradley Campbell to chief business officer. Mr Campbell joined Amicus in 2006 and most recently served as senior vice-president of business operations. He will continue to report to John Crowley, Amicus' chair and CEO.